The aim of this study was to analyze the impact of statin therapy at discharge upon 1-year mortality in patients with STEMI treated with primary angioplasty.

Ezetimibe Added to Statin Therapy Reduces LDL-C and Improves Goal Attainment in Patients with Hypercholesterolemia
Presented by Thomas A. Pearson, MD, PhD

The Ezetimibe Add-on to Statin for Effectiveness (EASE) trial was undertaken to examine the effectiveness and safety of ezetimibe, 10 mg, compared with placebo, added to any statin brand and dose in patients who were not at their NCEP ATP III LDL cholesterol goal despite statin monotherapy.

Women with Diabetes Mellitus Have the Greatest Reduction in Myocardial Infarction Mortality Over the Past Decade: Evaluation of 1, 428,596 Patients Enrolled in the Natioanl Registry of Myocardial Infarction 2, 3 and 4 from 1994-2002
Presented by Darren McGuire MD, MHSc

The goal of this analysis was to evaluate short-term mortality trends during the past decade among patients with MI according to DM status, especially among women with DM; trends in the prevalence of DM among MI patients; and trends in the use of evidence-based therapies.

Comparative Effects of Statins on Atherogenic Dyslipidemia In Patients with the Metabolic Syndrome
Presented by Prakash C. Deedwania, MD

This is the first study to assess in a randomized manner the comparative effect of four statins in patients with metabolic syndrome.

Should Statin Therapy Be Used Routinely in Pediatric Heart Transplant Recipients?
Presented by William T. Mahle, MD

It is unclear whether statin therapy should be routinely used in the pediatric heart transplant population. The aim of this retrospective analysis was to determine whether such statin therapy would reduce the risk of developing CAV in these children.

Association of Triglyceride to High-Density Lipoprotein Cholesterol Ratio With Heart Rate Recovery in Healthy Adults
Presented by Mehdi H. Shishehbor, MD

Investigators have identified significant association between heart rate recovery and TG/HDL-C ratio. In a retrospective analysis, the two factors together identify patients with insulin resistance who are at increased risk of death. By performing simple lipid measures and an exercise test, clinicians can obtain information that may be prognostically important in clinical practice.

Interventions in Patients with Diabetes
Presented by Spencer B. King, MD

The objective of the present study was to determine whether risk adjustment for the acute presentation of life-threatening cardiac and noncardiac conditions influences the relationship between low provider volume and adverse mortality outcomes.

Long-Term Effects of Statin Therapy in Patients With Acute ST-Elevation Myocardial Infarction and Moderate or Severe Left Ventricular Dysfunction: Reduction of Mortality but Not of Nonfatal Major Adverse Coronary and Cerebrovascular Events
Presented by Thomas Kleemann, MD

This trial was undertaken to evaluate the prognostic impact of early statin therapy in patients with moderate or severe left ventricular dysfunction (ejection fraction <40%) after acute ST-elevation MI.

Effect of Lipid Sub-fractions on Progression of Coronary Artery Disease Among Middle-aged Women
Presented by Adhir Shroff, MD

This analysis investigated the relationship of traditional and nontraditional lipid components and CAD progression in a cohort of women with established CAD using serial quantitative coronary angiography.

Electronic Clinical Reminders Effectively Identify Patients Not Meeting Guidelines
Presented by Jason H. Cole, MD

Electronic clinical reminders can effectively identify individual patients who are not being managed in accordance with national guidelines. These data can be provided as feedback to individual providers, clinics, medical centers, or systems.